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1. Introduction 
Bicuspid aortic valve (BAV) disease is the most common congenital cardiovascular 
malformation with prevalence of 1-2% in the human population (Hoffman, 1990; Hoffman & 
Kaplan, 2002). Current clinical and scientific studies reveal that bicuspid aortic disease is not 
a simple valve condition. It increasingly appears to be a genetically based connective tissue 
disorder. It has been reported that a molecular abnormality in the extracellular matrix may 
lead to abnormal cell differentiation during valvulogenesis; however, the exact mechanism 
remains unclear (Nataatmadja et al., 2003; Eisenberg et al., 1995; Fedak et al., 2002). An 
important problem is that the aorta of patients with BAV is not normal in strength or size. 
BAV is frequently associated with other cardiovascular malformations, including aortic root 
dilatation, aortic stenosis, coarctation of the aorta, and ventricular defects. Although 
symptoms often manifest in adulthood, there is a wide spectrum of presentations ranging 
from severe disease detected in utero to asymptomatic disease in old age. Complications can 
include aortic valve stenosis or incompetence, endocarditis, aortic aneurysm formation, and 
aortic dissection. Two large contemporary series have demonstrated that the life expectancy 
in adults with normally functioning BAV is not shortened when compared with that of the 
general population whereas age and severity of disease were associated with primary 
cardiac events (Michelena et al., 2008; Tzemos et al., 2008). The risk of aortic dilatation and 
aortic dissection is higher in patients with BAV than in the general population. In most of 
patients with BAV, symptoms and physical findings often are absent for many years, 
whereas the clinical consequences in patients with BAV are associated with regurgitation, 
endocarditis, and aortic aneurism and dissection. Endocarditis is an important complication 
for patients with BAV. It occurs particularly in patients with regurgitant or obstructive 
valves, although the risk of endocarditis may also be high also in hemodynamically stable 
patients. Prior studies reported significant mortality in patients with infected BAV. 
However, the last ACC/AHA guidelines recommend that antibiotic prophylaxis is not 
indicated in young patients and adolescents with BAV (Nishimura et al., 2008).  
Patients with moderate valvular dysfunction and normal left ventricular dimensions should 
be systematically monitored using echocardiography. In adition hypertension should be 
carefully followed by a cardiologist or cardiac surgeon with specific interest in this valve 
pathology. 
Adequate oral hygiene and antibiotic prophylaxis during dental procedures or when a poor 
cardiac condition is present are important for preventing endocarditis. Surgery is indicated 
for severe valvular dysfunction, symptomatic patients, and aortic dilatation. 
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This article addresses the embryology, genetic, pathophysiology, clinical presentation, 
diagnostic procedures, and therapeutic strategies for BAV. In this chapter we will present 
some cases with BAV with different prognoses from our clinic. 
2. Embryology 
The cardiac structure is evident from the second week of gestation, whereas separation of 
the heart into four chambers is completed during the sixth and seventh weeks of gestation, 
resulting in separated systemic and pulmonary circulation. The process of aortic valve 
morphogenesis begins from the cardiac cushions located in the ventricular outflow tract of 
the primary heart tube. The pathogenesis of BAV is still unclear. Studies in a Syrian hamster 
model with a high prevalence of BAV reported that fusion of the right and the left valve 
cushions is a key factor in the formation of BAV s (Sans-Coma et al., 2006). A previous study 
suggested that BAV is a consequence of the anomalous behavior of cells derived from the 
neural crest because BAV often is associated with congenital aortic arch malformations and 
other neural crest-derived systems (Kappetein et al., 1991). Other studies suggest that 
extracellular matrix proteins may affect the initiation of cell differentiation during 
valvulogenesis, while a molecular abnormality in this process may lead to the formation of 
abnormal cusps (Eisenberg et al., 1995; Fedak et al., 2002). 
These abnormalities cause the fusion of two cusps and lead to one larger cusp; therefore, the 
BAV usually includes two unequally sized cusps, the presence of a central raphe, and 
smooth cusp margin (Figure 1). A previous clinicopathologic study of a large group 
surgically excised congenital BAVs showed that raphal position was between the right and 
left cusp in 86% of cases (Sabet et al., 1999). An anomalous origin of coronary arteries 
depends on the spatial orientation of the two cusps. When the orientation of the cusps is 
anteroposterior, the coronary arteries originate from the anterior sinus or if cusps later-
lateral oriented the right coronary artery originate from the common trunk and right 
Valsava’s sinus (Schang et al., 1975). An anomalous origin of coronary arteries may be 
associated with myocardial hypoperfusion and angina pectoris. 
 
   
 RCA                                   LCA    RCA                                  LCA    RCA                                 LCA 
                   (a) (86%)                                         (b) (12%)                                       (c) (3%) 
Fig. 1. The morphologic pattern of BAV. (a): Fusion of the right-coronary and left-coronary 
leaflets. (b): Fusion of the right-coronary and non-coronary leaflets. (c): Fusion of the left-
coronary and non-coronary leaflet. RCA, right coronary artery. LCA, left coronary artery. 
The red dotted line indicate the raphal position 
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3. Genetics of the bicuspid aortic valve 
BAV is a complex congenital disease; therefore, its etiology remains unclear, but genetic factors 
have been proposed. Most BAV s occur as an isolated congenital defect; however, a study on 
41 families with a family member having surgically corrected BAV reported the prevalence 
of BAV to be at least 14.6% (Emanuel et al., 1978). A much more recent study in 50 probands 
with BAV concluded that the heritability (h) of BAV was 89%, and suggested that in this 
population, BAV is almost entirely genetic (Cripe et al., 2004). Two studies have identified 
genomic regions responsible for cardiovascular congenital disease associated with BAV. The 
first genetic cause of BAV is Anderson syndrome, which is reported to be a result of mutations 
in the KCNJ2 gene, whereas it clinically presents as ventricular arrhythmias, periodic 
paralysis, and scoliosis (Andelfinger et al., 2002). Another study in a large family with 
autosomal-dominant aortic valve disease diagnosed using genome-wide linkage analysis 
suggests that NOTCH1 gene mutations mapped to chromosome 9q-34 are responsible for 
the early developmental defect in the aortic valve (Garg et al., 2005). These studies are very 
important for understanding the complex etiology of congenital valvular disease, and they 
may help us to develop novel therapeutic strategies for preventing and treating BAV.  
4. Congenital cardiovascular syndromes associated with bicuspid aortic 
valve  
4.1 Coarctation of the aorta  
It has been reported that BAV is presented in > 50 % of patients with coarctation of the aorta 
(COA) (Duran et al., 1995). Patients with COA and BAV are reported to have more severe 
disease associated with aortic stenosis, aortic regurgitation, and aortic aneurysm. The risk of 
dissection of the aorta and death is greater when COA and BAV are comorbid (Abbott, 
1928). Microfibrilar proteins such us fibrillin -1 may be deficient during valvulogenesis, 
which could reduce the structural integrity both in the aortic valve and aorta. Aortic 
dysregulation is associated with increased activity of metalloproteinases, which may have 
impact on fibrillin-1 (McMillan ,et al., 1997). 
4.2 Turner syndrome 
Turner syndrome characterized by a defect in or the absence of one X chromosome. Except 
for gonadal dysgenesis, cardiovascular defects are commonly present in this group of 
patients. Clinical research on patients with Turner Syndrome reports that BAV is present in 
30% of cases, that over 95% of BAV s result from fusion of the right and left coronary 
leaflets, and that aortic ascending diameters are significantly greater in this group of 
patients (Miller et al., 1983; Sachdev et al., 2008).  
4.3 Patent ductus arteriosus  
Patent ductus arteriosus is usually obliterated during the first month of life (Mitchell, 1957; 
Reller et al., 1988; Mandorla et al., 1990; Lim et al., 1992). Patent ductus arteriosus is usually 
present in pediatric patients with BAV and may be associated with hand anomalies (Gelb et 
al., 1999). 
4.4 Williams syndrome 
Williams Syndrome is arteriopathy characterized by supravalvular aortic stenosis which 
may be associated with COA, renal artery stenosis, and arterial hypertension. Williams 
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syndrome has also been associated with complete atrioventricular septal defect (Nakamoto 
et al., 2003), and is reported to be commonly present in patients with BAV (Sugayama et al., 
2003; Hallidie-Smith & Karas, 1988). 
4.5 Ventricular septal defect 
Ventricular architecture may be characterized by complex malformation during 
embryogenesis involving both septation and valve formation. Ventricular septal defects are 
often associated with BAV and other complex congenital malformations (Oppenheimer- 
Dekker et al., 1985) . BAV is reported to be present in up to 30 % of adult patients with small 
ventricular septal defects (Neumayer et al., 1988). However, BAV may also be associated 
with large ventricular septal defects and poor clinical outcome (Berisha et al., 2009).  
5. Pathophysiology 
Valve leaflet morphology and orientation are competent for pathophysiology of left heart. 
Adhesions of commissures and cusp calcifications predisposes to eventual stenosis, 
hemodynamically presented by different pressures between left ventricle (LV) and the 
ascending aorta during the systolic and diastolic period. Aortic stenosis is the most common 
complication of BAV, whereas aortic regurgitation is reported to be present in 13% of cases 
(Sabet et al., 1999). Turbulent flow along the abnormal structure of the BAV leads to fibrotic 
changes and stenotic progression. The pressure differences in stenotic patients with BAV are 
important because deviation from normal flow can cause important changes, in both the LV 
and the ascending aorta. High LV pressure in BAV increases wall stress, which results in the 
generation of concentric ventricle hypertrophy. Previous studies suggest that mechanical 
stimuli of myocytes can induce ventricular hypertrophy by specific gene expression, 
possibly via protein kinase C activation (Komuro et al., 1991, 1999). Progressively over time, 
the LV becomes more hypertrophic and less compliant, which contributes to a reduction of 
LV function. At this point, reduced stroke volume and cardiac output may lead to 
congestive heart failure. Post-stenotic dilatation may be a result of prolonged and severe 
aortic stenosis. Abnormal flow along the wall of the aorta can vibrate the vessel wall at 
different frequencies (Boughner & Roach, 1971), and may directly modulate elastin, whereas 
histopathological findings in congenital cardiac syndromes show medial degeneration and 
decreased fibrillin-1 in the aortic wall (Nataatmadja et al., 2003); however, the exact 
mechanism causing aortic dilatation in patients with BAV is unclear. 
BAV may be associated with abnormal coronary arteries or the coronary ostium may be 
stenotic (Roberts, 1970), while angina pectoris is reported to be present in patients with 
severe aortic stenosis and without coronary disease (Julius et al., 1997) .Wall stress during 
systole and diastole, and impaired LV relaxation in severe aortic stenosis, reduces the 
coronary flow reserve and causes subendocardial underperfusion; however, the exact 
mechanisms of angina pectoris in BAV are not very clear. 
Aortic regurgitation in patients with BAV is a result of cusp prolapse, fibrotic retraction, or 
dilatation of the sinotubular junction. BAV tends to become progressively more stenotic or 
regurgitant over time, and the valve becomes the site of infective endocarditis. Endocarditis 
is a result of turbulent flow, which induces chronic abrasion and abscess formation. 
Endocarditis can cause valve destruction and lead to severe aortic incompetence associated 
with a poor clinical outcome. 
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6. Clinical presentation 
The clinical presentation of patients with BAV can vary from severe valve disease in infancy 
to asymptomatic valve disease in old age. Disease is more severe and has poor clinical 
outcomes in infants with BAV comorbid with aortic stenosis (Hastreiter et al., 1963; Moller 
et al., 1966). 
Symptoms are a result of valvular stenosis, regurgitation, endocarditis, and aortic 
complications such as dilatation and dissection. Symptoms associated with aortic stenosis 
are angina pectoris, syncope, and congestive heart failure. Stenosis is more rapid if the aortic 
cusps are asymmetrical or anteroposteriorly oriented (Ward, 2008). Angina pectoris occurs 
in patients with severe aortic stenosis and in those who do not have coronary artery disease; 
it may be a result of ventricular hypertrophy. 
Syncope is another common symptom in patients with BAV. Syncope reflects the cerebral 
hypoperfusion caused by the inability to increase stroke volume during physical activity. 
The most common complication of aortic stenosis is congestive heart failure symptomatically 
presented with dyspnea, which is a result of combined diastolic and systolic dysfunction 
caused by elevated afterload and increased filling pressures. 
Aortic regurgitation reported to be more common in young patients and caused by prolapse 
of the greater cusp, which may associated with aortic root dilatation. Although young 
patients with BAV often are asymptomatic, echocardiographic studies show that 47% of this 
group of patients have some degree of incompetence (Michelena et al., 2008). Aortic 
regurgitation in patients with BAV carries an increased risk of endocarditis. If a patient with 
BAV complians of fever, weakness, and chest pain, endocarditis may be present. 
Endocarditis occurs in 10-30% of patients with BAV and can lead to valve perforation or 
destruction (Ward, 2008). 
Aortic dilatation and dissection can be echocardiographcally diagnosed in patients with 
minimal valvular dysfunction even when they are asymptomatic; therefore, the risk of aortic 
dissection in patients with BAV may be higher than clinical presentation. Aortic dilatation 
may be progressive and often requires surgical correction (Duran et al., 1990; Sabet et al., 
1999). 
The clinical presentation in patients with BAV and presence of other cardiac congenital 
defects depends from structural complexity of the heart. In patients with COA, the presence 
of hypertension increases the risk of aortic dissection, considering that congenital 
abnormalities of the aortic wall are also involved. Patient may complain of chest pain, 
hoarseness, and respiratory difficulties. In adult patients with interventricular septal defects, 
the clinical presentation depends on the size of the defect area and the grade of aortic 
stenosis. If the interventricular defect is small, the patient may be asymptomatic, but when 
the interventricular defect is large, cardiac output will decrease and Eisenmenger syndrome 
will develop. Eisenmenger syndrome clinically presents with central cyanosis and shortness 
of breath during physical activity. However, during that the BAV becomes thicker, more 
fibrotic, and more calcified, and if is not surgically corrected cardiac output will decrease 
dramatically and may lead to cardiac death.  
Two large recent series reported that clinical course of unoperated patients with BAV 
depends on age, stenosis, and aortic incompetence (Michelena et al., 2008; Tzemos et al., 
2008). The severe aortic stenosis, and severe aortic incompetence in older patients increases 
the risk of primary cardiac events including cardiac death. Both these studies suggest that 
intervention on the basis of early symptoms or incipient cardiac dysfunction may decreases 
the mortality of patients with BAV. 
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7. Diagnosis 
7.1 Physical examination 
A physical examination is very helpful for evaluating the complications of BAV. Munt et al. 
(1999) reported that the amplitude of the pulse in the carotid artery was a significant 
predictor of outcome in patients with valvular aortic stenosis. If stenosis is present, the 
arterial pulse is small or weak and rises slowly, described as “parvus et tardus”. The cardiac 
pulse at the apex initially is normal; however, arterial pulse is delayed and reduced in 
amplitude if evaluated by palpation of the carotid artery. Auscultatory findings are best 
heard in the left second intercostal space. The S1 usually is normal but sometimes may be 
associated with ejection click. The S2 is soft, and when aortic stenosis is present, S2 occurs 
simultaneously with P2. In aortic stenosis, an ejection systolic murmur is heard in the left 
second intercostal space but may also be transmitted to the carotid arteries. If aortic 
incompetence is present, a diastolic murmur of aortic regurgitation may be heard.  
7.2 ECG  
The ECG changes are not specific in patients with BAV: left ventricular hypertrophy, atrial 
enlargement, and arrhythmias may be present.  
7.3 Echocardiography 
The most important diagnostic method for first detecting and evaluating complications in 
patients with BAV is echocardiography. A transthoracic echocardiogram (TTE) considered 
the method of choice for evaluating valvular structure, calcifications, vegetations, cardiac 
chamber structure, and ejection fraction. Doppler methods are the most common techniques 
used for evaluating valvular regurgitation. For BAV associated with stenosis, mean gradient 
and maximal flow velocity should be measured, but when regurgitation is present, the 
effective regurgitant area (ERO) and Doppler jet size should be evaluated (Quinones, et al., 
2002; Zoghbi et al., 2003). Based on recommendations for evaluating the severity of native 
valvular regurgitation with two-dimensional and Doppler echocardiography, aortic 
regurgitation is classified as mild, moderate, and severe (Zoghbi et al., 2003). In 2006, 
ACC/AHA published guidelines for the management of patients with valvular disease in 
which aortic stenosis classified as mild, moderate, or severe (Table 1). For asymptomatic 
patients with aortic stenosis, echocardiography is recommended for evaluating disease 
progression. In asymptomatic patients, TTE recommended: every year for severe aortic 
stenosis, ever 1-2 years for moderate aortic stenosis and every 3-5 years for mild aortic 
stenosis (Bonow et al., 2006). Transesophageal echocardiography (TEE) is also very  
 
Indicator Mild Moderate Severe 
Jet velocity (m per second) < 3.0 3.0-4.0 > 4.0 
Mean gradient (mmHg) < 25 25-40 > 40 
Valve area (cm²) < 1.5 1.0-1.5 < 1.0 
Valve area index (cm per m²)   < 0.6 
Modified from Bonow et al.,(2006). ACC/AHA Practice Guidelines. Circulation 114, pp. e84-e231. 
Table 1. Classification of the severity of aortic stenosis 
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important for evaluating the aortic valve and thoracic aorta, whereas the sensitivity and 
specifity of multiplane technique for assessing aortic valve morphology is high (Alegret et 
al., 2005; Espinal et al., 2000).  
7.4 Other diagnostic procedures  
In patients with poor acustic window, cardiac magnetic resonance (MR) and multidetector 
computed tomography (CT) are useful for measuring the aortic valve area and is an 
alternative method to echocardiography in selected cases (Shelton et al., 2003; Pouleur et al., 
2007). MR imaging is an essential method for diagnosing COA and root aneurism. 
8. Endocarditis prophylaxis 
The most common bacteria that causes the formation of perivalvular abscess is Staphylococcus 
aureus. Indications for antibiotic prophylaxis in patients with BAV are before procedures 
expected to produce bacteremia; however, new ACC/AHA guidelines recommend that 
antibiotic prophylaxis is no longer indicated for preventing of infective endocarditis in 
adolescents and young adults with native heart valve disease (Nishimura et al., 2008). This 
committee concluded that infective endocarditis prophylaxis for dental procedures is 
reasonable only for patients with cardiac conditions associated with a high risk of adverse 
outcomes from infective endocarditis (Table 2).  
 
Procedures  Antibiotics 
Dental : Amoxicillin, Ampicillin 
Manipulation of gingival tissue Penicillin allergic: 
Manipulation of periapical region of teeth Clindamycin, Cefalexin, Cefadroxil, Cefazolin 
Perforation of oral mucosa Azithromycin, Clarithromycin, Clindamycin 
 
Prophylaxis is not recommended for patients who undergo a:   
- Genitourinary procedure     
- Gastrointestinal procedure         
Nishimura et al., (2008). J Am Coll Cardiol 52,676-685. 
Table 2. Recommendations for antibiotics for endocarditis prophylaxis before procedures 
9. Treatment 
When to surgically treat asymptomatic patients with BAV remains controversial. Sometimes 
aortic stenosis correlates poorly with clinical presentation; however, if it is combined with 
regurgitation, symtoms might be present. The risk of sudden death in asymptomatic adult 
patients with severe aortic stenosis is reported to be less than 1% per year (Pellika et al., 
2005). Bonow et al., (2007) and Iung B et al. (2003) reported that valve replacement is not 
recommend for asymptomatic patients; however, current practice guidelines recommended 
aortic valve replacement in patients with reduced left ventricular systolic function (EF< 50%) 
without other explanation even when they are asymptomatic (Table 3).  
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Class I Class II b 
1. Indicated for symptomatic patients 
with severe aortic stenosis 
1. Asymptomatic with severe aortic 
stenosis and abnormal response to 
exercise 
2. Indicated for severe aortic stenosis and 
undergoing CABG 
2. Asymptomatic Adults with severe 
aortic stenosis and rapid progression 
3. Indicated for severe aortic stenosis and 
undergoing surgery on the aorta and 
other heart valves 
3. Mild aortic stenosis, undergoing CABG, 
rapid progressions 
4. Indicated for severe aortic stenosis and 
LV  dysfunction EF less than 0.50 
4. Asymptomatic with extremely severe 
aortic stenosis (when mortality ≤1%) 
Class II a Class III 
1. Indicated for moderate aortic stenosis 
and undergoing CABG or surgery of 
the aorta and other heart valves  
1. AVR is not recommended for 
preventing  sudden cardiac death in 
patients who have non of the findings 
listed in IIa and IIb 
CABG, coronary artery bypass graft. AVR, aortic valve replacement; 
Bonow et al. (2006). 
Table 3. Indications for aortic valve replacement in patients with aortic stenosis 
 
Class I Class IIa 
Patients with bicuspid aortic valve and 
dilatation of the aortic root or ascending aorta 
(diameter > 4.0 cm) should undergo serial 
evaluation of aortic root/ascending aorta size 
and morphology by echocardiography, CMR 
or CT on a yearly basis. 
It is reasonable to give b-adrenergic 
blocking agents to patients with BAV 
and dilated aortic roots (diameter >than 
4.0 cm) who are not candidates for 
surgical correction and who do not have 
moderate to severe AR. 
Surgery to repair the aortic root or replace the 
ascending aorta is indicated in patients with 
BAV if the diameter of aortic root or 
ascending aorta is greater than 5.0 cm or if the 
rate of increase in diameter is 0.5 cm per year 
or more. 
CMR imaging or cardiac CT is 
reasonable in patients with BAV when 
aortic root dilatation is detected by 
echocardiography to further quantify 
severity of dilatation and involvement of 
the ascending aorta. 
In patients with BAV undergoing AVR 
because of severe AS or AR, repair of the 
aortic root or replacement of the ascending is 
indicated if the diameter of the aortic root or 
ascending aorta is grater than 4.5 cm. 
 
CMR= cardiac magnetic resonance, CT= computed tomography. Bonow et al. (2006). 
Table 4. Evaluation and Treatment of Dilated Ascending Aorta in patients with Bicuspid 
Aortic Valve ACC/AHA 2006 Guidelines for the management of patients with valvular 
heart disease 
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Risk factor EuroSCORE Points 
Age (years)       
< 60      0  
60-64      1  
65-69      2  
70-74      3  
75-79      4  
80-84      5  
85-89      6  
90-94      7  
>95      8  
Sex        
Female      1  
Chronic pulmonary disease    1  
Extracardiac arteriopathy    2  
Neurological dysfunction    2  
Previous cardiac surgery    3  
Serum creatinine > 200 µM/L    2  
Active endocarditis     3  
Critical preoperative state    3  
Unstable angina     2  
LV dysfunction :       
LVEF 30-50%     1  
LVEF < 30%     3  
Recent  MI < 90 days     2  
Pulmonary hypertension, PSAP>60mmHg   2  
Emergency     2  
Major cardiac procedure other than CABG   2  
Surgery of thoracic aorta    3  
Post- infarct septal rupture    4  
LVEF=left ventricular ejection fraction, MI= myocardial infarction, CABG=coronary artery bypass grafting 
Roques et al. (1999). 
Table 5. Score risk classification in the EuroScore 
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Elective surgery in patients with severe stenosis can prevent sudden cardiac death, and 
irreversible cardiac damage, and decrease operative risk. Coady et al., (1997) reported that 
the growth rate for the ascending segment of the aorta is 0.1 to 0.15 cm per year; therefore, 
older patients and those who have hypertension must be carefully followed-up and should 
be informed about the symptoms of aortic dissection. According to the ACC/AHA 
guidelines, patients with a dilated aortic root or an ascending aorta > 5.0 cm, or if the rate of 
increase in diameter > 0.5cm per year, should undergo simultaneous AVR and ascending 
aortic replacement (Table 4). 
AVR carries a high risk for adverse events and poor clinical outcome when associated with 
LV dysfunction. In patients with functional class NYHA III-IV after aortic replacement, the 
one year mortality increased especially in patients with aortic stenosis (Rothenburger et al., 
2003). Based on factors predicting operative mortality, which have been identified form 
large series of patients undergoing heart-valve surgery, The Task Force on the Management 
of Valvular Heart Disease of the European Society of Cardiology proposed risk classification 
scores for this group of patients (Vahanian et al., 2007) (Table 5). 
For high-risk patients to undergo conventional novel methods including aortic balloon 
valvulotomy or transfemoral valve implantation may be helpful. This method reduced one-
year mortality from 50.7% in the standard therapy group to 30.7% in transcatheter aortic-
valve implantation group (Leon et al., 2010). A patient considered inoperable should be 
treated orally with angiotensin converting enzyme (ACE) inhibitors, diuretics, and digitalis. 
In patients with depressed LV associated with pulmonary congestion and atrial fibrillation, 
diuretics and digitalis may be used with the understanding that in some cases intensive 
hemodynamic monitoring is needed. Patients with aortic root dilatation > 4.0cm who are not 
candidate for surgical treatment should be given β-adrenergic blocking agents. 
10. Case presentations 
Case 1 
History 
- 42- year- old man referred for chest pain and shortness of breath. 
- No previous cardiovascular disease 
- CAD risk factors present: smoking, hypertension. 
Physical examination 
- BP: 140/80 mmHg, Hr: 64/min 
- Arterial pulse is small and rises slowly, “parvus et tardus” 
- Heart rhythm regular, fourth heart sound (S4), systolic murmur heard at the base of the 
heart Gr. 4/6  
Other diagnostic procedures 
- ECG: sinus rhythm, Hr: 64/min, biphasic T in D2, D3, AVF, ST segment depression for 
0.5mm in V5 and V6 with biphasic T. 
- TTE: cardiac chambers with normal dimensions, EF: 55%, aortic valve is bicuspid with 
vertical commissure, cusps are unequal, aortic valve area: 1.85cm², V mean: 131 cm/s, 
VTI: 41.9cm, Mean pressure gradient: 8 mmHg, aorta: 2.90 cm, (Figure 2 and 3). 
- TEE: Bicuspid aortic valve with vertical commissure, cusps are unequal, aortal 
regurgitation (Figure 4). 
- Coronary angiography: normal coronary arteries.  
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                                    (a)                                                                             (b) 
Fig. 2. TTE: (a) Parasternal short axis view: BAV during systole, (b) Parasternal short axis 
view: aortic valve area 
 
  
                                      (a)                                                                             (b) 
Fig. 3. TTE: (a) Normal haemodinamic parameters , (b) Parasternal long axis view: Aortic 
diameter 
 
  
                                      (a)                                                                             (b)  
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(c) 
Fig. 4. TEE: (a) Short axis view: BAV during systole, (b) Short axis: BAV during diastole,  
(c) Aortic regurgitation 
Comments 
- Aortic valve replacement was not indicated in this patient because has no more 
symptoms, valve area is 1.85cm², aortic dimensions are normal, and LV systolic function 
is normal at rest (EF> 50) 
Treatment 
- Prescribed ACE inhibitor, endocarditis prophylaxis therapy, recommended serial 
evaluation using echocardiograpy. 
Case 2 
History 
- 57- year- old man referred for chest pain, shortness of breath and syncope. 
- No previous cardiovascular disease. 
- No CAD risk factors present. 
Physical examination 
- BP: 120/80 mmHg, Hr: 85/min. 
- Arterial pulse in apex is normal while in carotid artery is small. 
- Heart rhythm iregular, soft systolic murmur heard at the base of the heart and radiated 
at the apex. 
Other diagnostic procedures 
- ECG: atrial fibrillation, Hr: 85/min, ST segment depression for 0.5mm in DI, AVL, V2 -V6. 
- TTE: Left cardiac chambers enlarged especially LA,  
EF: 45%, aortic valve is artificial, Vel: 1.82m/s, PG: 13.2mmHg, incipient dilatation of aorta 
(Figure 5). 
Treatment 
- Before surgical treatment: prescribed β-adrenergic blocking agents, anti-angina drugs, 
endocarditis prophylaxis therapy and recommended surgical correction of BAV. 
- After surgical treatment: β-adrenergic blocking agents, anticoagulation therapy, 
recommended serial evaluation using echocardiography.  
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                                      (a)                                                                             (b)  
  
                                      (c)                                                                             (d) 
Fig. 5. TTE: (a) Artificial aortic valve (parasternal short axis view), (b) Apical five chamber 
view, (c) and (d) Parasternal long axis view: incipient aortic dilatatation and LA enlargement 
Comments 
- In this patient we recommended aortic valve replacement because he was symptomatic 
for several months, he had aortic regurgitation, incipient aortic dilatation, decreased 
systolic function at rest (EF> 45%). 
- After surgical treatment, patient remained stable and without any postoperative 
complication. 
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